Plant Bioscience gains two US RNAi patents
The UK technology transfer company, Plant Bioscience (Norwich, Norfolk), has been granted two US patents related to RNAi and gene silencing. Patent 8,779,236 covers cells containing DNA constructs expressing RNAi molecules that silence RNA in a pest, parasite, predator or pathogen. Patent 8,759,102 covers cells comprising synthetic DNA constructs that express RNAi molecules to silence target RNA in these cells. The latest patents bring Plant Bioscience's RNAi patent portfolio to nine. The company has granted licences to partners in the agricultural biotechnology, animal health and pharmaceutical sectors. It is equally owned by the John Innes Centre, the Sainsbury Laboratory and the Biotechnology and Biological Sciences Research Council.